#Consumerbell Blog quotes FDA as undecided on a #recall, at this time, of #DRSP #DROSPIRENONE containing birth control pills. Whether a recall or significant restrictions on use will result from FDA hearings on 12.8.11 remains open to debate. Critics question what the #DRSP #DROSPIRENONE family of pills add to available birth control options if they are not safer. FDA funded study confirmed a significantly higher risk of blood clots and noted it was 1.74x relative risk in comparison to alternative pills. Other studies confirm even higher risk, thus setting stage for debate at public hearings.